Steward Partners Investment Advisory, LLC - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 1 filers reported holding PLX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of PLX PHARMA INC
ValueSharesWeighting
Q2 2023$123
-97.8%
43,8750.0%0.00%
Q1 2023$5,708
-22.5%
43,875
-2.2%
0.00%
Q4 2022$7,364
-81.1%
44,875
-25.6%
0.00%
-100.0%
Q3 2022$39,000
-75.5%
60,355
-7.7%
0.00%
-66.7%
Q2 2022$159,000
-43.8%
65,355
-6.8%
0.00%
-25.0%
Q1 2022$283,000
-40.5%
70,148
+18.0%
0.00%
-42.9%
Q4 2021$476,000
-40.1%
59,448
+44.5%
0.01%
-50.0%
Q3 2021$794,000
+443.8%
41,148
+288.4%
0.01%
+600.0%
Q2 2021$146,000
-99.9%
10,593
-41.8%
0.00%
+100.0%
Q1 2021$164,220,00018,186
+24148.0%
0.00%
Q2 2018$0750.00%
Other shareholders
PLX PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 1,875,000$4,556,0000.28%
Ground Swell Capital, LLC 48,931$119,0000.22%
Park West Asset Management LLC 1,473,218$3,580,0000.20%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$152,0000.07%
Eidelman Virant Capital 27,000$63,0000.04%
MBL Wealth, LLC 52,000$1260.03%
O'Brien Greene & Co. Inc 22,340$54,0000.02%
SHUFRO ROSE & CO LLC 56,800$138,0000.01%
GW&K Investment Management, LLC 424,921$1,033,0000.01%
EXANE DERIVATIVES 6,575$15,974,0000.01%
View complete list of PLX PHARMA INC shareholders